C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/28 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C12N 15/13 (2006.01) G01N 33/53 (2006.01) G01N 33/566 (2006.01)
Patent
CA 2698609
The present invention relates to the use of VEGF antagonists and a novel anti-a5ß1 antibody for treating cancer and inhibiting angiogenesis and/or vascular permability, including inhibiting abnormal angiogenesis in diseases. The present invention also relates to compositions and kits comprising novel anti-a5ß1 antibodies and methods of making and using them.
La présente invention concerne l'utilisation d'antagonistes du VEGF et un nouvel anticorps anti-a5ß1 pour traiter le cancer et inhiber l'angiogenèse et/ou la perméabilité vasculaire, y compris pour inhiber l'angiogenèse anormale dans des maladies. La présente invention concerne également des compositions et des kits comprenant de nouveaux anticorps anti-a5ß1 et des procédés pour les fabriquer et les utiliser.
Liang Wei-Ching
Plowman Gregory D.
Wu Yan
Ye Weilan
Genentech Inc.
Smart & Biggar
LandOfFree
Novel antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1969743